Welcome to our dedicated page for Beyondspring SEC filings (Ticker: BYSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BeyondSpring Inc. (NASDAQ: BYSI) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a clinical-stage biopharmaceutical company. This SEC filings page aggregates those disclosures and, with AI-powered summaries, helps investors interpret the information most relevant to BeyondSpring’s oncology pipeline and capital structure.
Core filings include the annual report on Form 10‑K, which contains audited consolidated financial statements, notes on research and development spending, general and administrative expenses, net loss from continuing operations, and the presentation of SEED Therapeutics as discontinued operations. Current reports on Form 8‑K document material events such as quarterly financial results, equity offerings under an effective shelf registration statement, updates on the sale of BeyondSpring’s Series A‑1 preferred shares in SEED Therapeutics, and scheduling of the annual meeting of shareholders.
Investors can also review proxy materials, such as the definitive proxy statement on Schedule 14A, which outlines matters submitted to shareholder vote, including ratification of the independent registered public accounting firm. Additional 8‑K filings describe share purchase agreements, lock-up provisions for investors in registered offerings, and changes in BeyondSpring’s ownership percentage in SEED following new financing rounds.
Stock Titan’s AI tools assist by highlighting key elements in lengthy filings: trends in research and development and general and administrative expenses, cash and cash equivalents, deferred revenue, shareholders’ deficit, and noncontrolling interests. The platform also flags items related to capital raises, registration statements, and governance events. Real-time integration with EDGAR means new 10‑K, 8‑K, S‑3, and proxy filings for BYSI appear quickly, while AI-generated overviews help readers understand how each document fits into BeyondSpring’s broader clinical and financing strategy.